Australia's Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific

doi:10.3390/vaccines9080921

Review

. 2021 Aug 18;9(8):921.

doi: 10.3390/vaccines9080921.

Australia's Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific

Zheng Quan Toh^{1

2}, Chau Quang^{1

2}, Joseph A Tooma³, Suzanne M Garland^{1

4

5}, Kim Mulholland^{1

2

6}, Paul V Licciardi^{1

2}

Affiliations

¹ Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
² Department of Paediatrics, The University of Melbourne, Parkville, VIC 3052, Australia.
³ Australia Cervical Cancer Foundation, Fortitude Valley, QLD 4006, Australia.
⁴ Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC 3052, Australia.
⁵ Regional WHO HPV Reference Laboratory, Centre Women's Infectious Diseases Research, The Royal Women's Hospital, Parkville, VIC 3052, Australia.
⁶ Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

PMID: 34452046
PMCID: PMC8402478
DOI: 10.3390/vaccines9080921

Review

Australia's Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific

Zheng Quan Toh et al. Vaccines (Basel). 2021.

. 2021 Aug 18;9(8):921.

doi: 10.3390/vaccines9080921.

Authors

Zheng Quan Toh^{1

2}, Chau Quang^{1

2}, Joseph A Tooma³, Suzanne M Garland^{1

4

5}, Kim Mulholland^{1

2

6}, Paul V Licciardi^{1

2}

Affiliations

¹ Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
² Department of Paediatrics, The University of Melbourne, Parkville, VIC 3052, Australia.
³ Australia Cervical Cancer Foundation, Fortitude Valley, QLD 4006, Australia.
⁴ Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC 3052, Australia.
⁵ Regional WHO HPV Reference Laboratory, Centre Women's Infectious Diseases Research, The Royal Women's Hospital, Parkville, VIC 3052, Australia.
⁶ Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

PMID: 34452046
PMCID: PMC8402478
DOI: 10.3390/vaccines9080921

Abstract

Australian researchers have made substantial contributions to the field of vaccinology over many decades. Two examples of this contribution relate to pneumococcal vaccines and the human papillomavirus (HPV) vaccine, with a focus on improving access to these vaccines in low- and lower-middle-income countries (LLMICs). Many LLMICs considering introducing one or both of these vaccines into their National Immunisation Programs face significant barriers such as cost, logistics associated with vaccine delivery. These countries also often lack the resources and expertise to undertake the necessary studies to evaluate vaccine performance. This review summarizes the role of Australia in the development and/or evaluation of pneumococcal vaccines and the HPV vaccine, including the use of alternative vaccine strategies among countries situated in the Asia-Pacific region. The outcomes of these research programs have had significant global health impacts, highlighting the importance of these vaccines in preventing pneumococcal disease as well as HPV-associated diseases.

Keywords: alternative vaccine schedules; human papillomavirus vaccine; pneumococcal vaccines; vaccine evaluation and Australia.

PubMed Disclaimer

Conflict of interest statement

S.M.G. has received grants through her institution from Merck Sharp & Dohme (MSD)and has delivered lectures and received speaking fees from MSD for work performed in her personal time. All other authors report no conflicts of interest. All other authors declare no conflict of interest.

References

1. Turner H.C., Thwaites G.E., Clapham H.E. Vaccine-preventable diseases in lower-middle-income countries. Lancet Infect. Dis. 2018;18:937–939. doi: 10.1016/S1473-3099(18)30478-X. - DOI - PubMed
1. Guignard A., Praet N., Jusot V., Bakker M., Baril L. Introducing new vaccines in low- and middle-income countries: Challenges and approaches. Expert. Rev. Vaccines. 2019;18:119–131. doi: 10.1080/14760584.2019.1574224. - DOI - PubMed
1. Berical A.C., Harris D., Dela Cruz C.S., Possick J.D. Pneumococcal Vaccination Strategies. An Update and Perspective. Ann. Am. Thorac. Soc. 2016;13:933–944. doi: 10.1513/AnnalsATS.201511-778FR. - DOI - PMC - PubMed
1. Wahl B., O’Brien K.L., Greenbaum A., Majumder A., Liu L., Chu Y., Luksic I., Nair H., McAllister D.A., Campbell H., et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: Global, regional, and national estimates for 2000-15. Lancet Glob. Health. 2018;6:e744–e757. doi: 10.1016/S2214-109X(18)30247-X. - DOI - PMC - PubMed
1. Murdoch D.R., Howie S.R.C. The global burden of lower respiratory infections: Making progress, but we need to do better. Lancet Infect. Dis. 2018;18:1162–1163. doi: 10.1016/S1473-3099(18)30407-9. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Turner H.C., Thwaites G.E., Clapham H.E. Vaccine-preventable diseases in lower-middle-income countries. Lancet Infect. Dis. 2018;18:937–939. doi: 10.1016/S1473-3099(18)30478-X. - DOI - PubMed

[2] Turner H.C., Thwaites G.E., Clapham H.E. Vaccine-preventable diseases in lower-middle-income countries. Lancet Infect. Dis. 2018;18:937–939. doi: 10.1016/S1473-3099(18)30478-X. - DOI - PubMed

[3] Guignard A., Praet N., Jusot V., Bakker M., Baril L. Introducing new vaccines in low- and middle-income countries: Challenges and approaches. Expert. Rev. Vaccines. 2019;18:119–131. doi: 10.1080/14760584.2019.1574224. - DOI - PubMed

[4] Guignard A., Praet N., Jusot V., Bakker M., Baril L. Introducing new vaccines in low- and middle-income countries: Challenges and approaches. Expert. Rev. Vaccines. 2019;18:119–131. doi: 10.1080/14760584.2019.1574224. - DOI - PubMed

[5] Berical A.C., Harris D., Dela Cruz C.S., Possick J.D. Pneumococcal Vaccination Strategies. An Update and Perspective. Ann. Am. Thorac. Soc. 2016;13:933–944. doi: 10.1513/AnnalsATS.201511-778FR. - DOI - PMC - PubMed

[6] Berical A.C., Harris D., Dela Cruz C.S., Possick J.D. Pneumococcal Vaccination Strategies. An Update and Perspective. Ann. Am. Thorac. Soc. 2016;13:933–944. doi: 10.1513/AnnalsATS.201511-778FR. - DOI - PMC - PubMed

[7] Wahl B., O’Brien K.L., Greenbaum A., Majumder A., Liu L., Chu Y., Luksic I., Nair H., McAllister D.A., Campbell H., et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: Global, regional, and national estimates for 2000-15. Lancet Glob. Health. 2018;6:e744–e757. doi: 10.1016/S2214-109X(18)30247-X. - DOI - PMC - PubMed

[8] Wahl B., O’Brien K.L., Greenbaum A., Majumder A., Liu L., Chu Y., Luksic I., Nair H., McAllister D.A., Campbell H., et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: Global, regional, and national estimates for 2000-15. Lancet Glob. Health. 2018;6:e744–e757. doi: 10.1016/S2214-109X(18)30247-X. - DOI - PMC - PubMed

[9] Murdoch D.R., Howie S.R.C. The global burden of lower respiratory infections: Making progress, but we need to do better. Lancet Infect. Dis. 2018;18:1162–1163. doi: 10.1016/S1473-3099(18)30407-9. - DOI - PubMed

[10] Murdoch D.R., Howie S.R.C. The global burden of lower respiratory infections: Making progress, but we need to do better. Lancet Infect. Dis. 2018;18:1162–1163. doi: 10.1016/S1473-3099(18)30407-9. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Australia's Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific

Affiliations

Australia's Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources